Angion

Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Angion swings for a $36M IPO as biotech's bear turn drags on
Fierce Biotech
Tue, 04/15/14 - 10:57 am
Angion
IPOs